Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Synvista Therapeutics Inc. (SYNI) Debt to Equity Ratio data is not available.
| Income Statement Financials | |
$0.05M |
|
$-16.09M |
|
-- |
|
$0.05M |
|
$9.95M |
|
$-9.90M |
|
$-6.19M |
|
$-16.09M |
|
$-16.09M |
|
$-16.09M |
|
$-16.09M |
|
$-16.09M |
|
$-16.09M |
|
$-9.90M |
|
$-3.43M |
|
2.59M |
|
2.59M |
|
$-7.71 |
|
$-7.71 |
|
| Balance Sheet Financials | |
$15.88M |
|
$0.01M |
|
$0.81M |
|
$16.70M |
|
$2.83M |
|
-- |
|
-- |
|
$2.83M |
|
$13.76M |
|
$13.87M |
|
$13.86M |
|
-- |
|
| Cash Flow Statement Financials | |
$-7.94M |
|
$-0.41M |
|
$22.53M |
|
$1.47M |
|
$15.64M |
|
$14.16M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.61 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-19800.00% |
|
-19800.00% |
|
-6860.00% |
|
-32180.00% |
|
-32180.00% |
|
$-7.95M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-116.96% |
|
-116.03% |
|
-96.37% |
|
-116.11% |
|
-- |
|
$-3.07 |
|
$-3.07 |
|